“Your Local Injury Lawyers Since 1985”


Please check back soon.


Please check back soon.


Please check back soon.


Please check back soon.


Please check back soon.

Talcum Powder

Please check back soon.


Please check back soon.

Andro Gel

Please check back soon.

Power Morcellators

Please check back soon.

Medtronic Infuse Bone Graft

Please check back soon.

Medtronic Insulin Pump

Please check back soon.

Zimmer NexGen Knee Replacements

Since 2003, more than 150,000 Zimmer NexGen Flex-Knee implants have been sold. Several different components used as part of the Zimmer NexGen Flex-Knee replacement systems have been associated with increased risk of complications, including pain, swelling, loosening of component parts, and the need for follow-up surgery.


Pradaxa® is a prescription medication manufactured by Boehringer Ingelheim. It is a blood thinning mediation used for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). In November 2011, Boehringer Ingelheim confirmed reports of 260 people worldwide suffering a fatal bleed while taking Pradaxa. In December 2011, the FDA issued a safety announcement that it is evaluating post-marketing reports of serious bleeding events in patients taking Pradaxa.


Paxil® is an anti-depressant manufactured by GlaxoSmithKline. Recently, Public Health Advisories have been issued for Paxil® regarding and increased risk of heart birth defects, persistent pulmonary hypertension (PPHN), omphalocele (an abnormality in newborns in which the infant’s intestine or other abdominal organs protrude from the navel) or craniosynostosis (connections between sutures-skull bones prematurely close during the first year of life, which causes an abnormally shaped skull) in children born to mothers exposed to Paxil®.


is an IUD that was originally approved by the FDA as an intrauterine contraceptive. It was later approved as a treatment for heavy menstrual bleeding. It works by slowly releasing a low dose of levonorgestrel (a synthetic progestin hormone) directly into the uterus. Serious adverse side effects and potentially life-threatening complications have been reported following the implantation of the device, including organ perforation, migration of the IUD to outside the uterus, expulsion of the IUD, and embedment in the uterus.


a statin drug to treat high cholesterol, was approved by the FDA in 1996 and is one the best-selling prescription medications in the world. Recent studies have found a possible link between Lipitor and the risk of developing Type 2 diabetes. A University of Massachusetts study found a potential link in postmenopausal women, particularly those who had a Body Mass Index (BMI) less than 25. Of the 153,840 women evaluated, more than 10,000 had developed Type 2 diabetes by the end of the study.


Granuflo® and NaturaLyte® are products used in the dialysis process. On June 27, 2012, the FDA issue a Class 1 recall of GranuFlo® and NaturaLyte®. A Class 12 recall is the most serious FDA recall, reserved for situations in which the FDA deems “there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.” Use of these dialysis products has been linked to an increase risk of cardiopulmonary arrest and sudden cardiac death. The manufacture, Fesnius Medical Care, was aware of the dangers and injuries associated with these products, but failed to warn patients and doctors until 2012. If you are impacted by these findings, you could benefit from consulting a drug recall attorney. Mobile, AL residents should not feel powerless; instead, look to Moore Law Firm for guidance.


Fosamax is a type of medication known as a bisphosphonate, prescribed for the treatment of bone loss and osteoporosis. In October of 2010 the FDA required all manufacturers of bisphosphonates to include a warning section of their label describing the risk of thigh fractures associated with the use of drugs in this class. Fosamax has also been linked to bone decay such as osteonecrosis of the jaw.


The FDA has approved updated drug labels for Actos, usually prescribed to treat Type 2 Diabetes. This medication has been linked to an increased risk of bladder cancer if taken for more than one year.

Metal-on-Metal Hip Replacement Parts

The FDA has ordered a review of all metal-on-metal hip implants due to mounting patient complaints. Problems with the metal-on-metal devices include loosening, fracturing and dislocating of the devices caused by inflammation in the joint space. We are investigating all cases involving metal-on-metal hip implants, including the DePuy hip implants, the Smith & Nephew implants, DePuy Pinnacle implants, the Zimmer Durom Cup, the Wright Conserve, and the Biomet M2A. These implants have yet to be recalled. If you, a family member, or a friend has a hip implant and have pain, swelling and problems walking them please contact our firm.

Transvaginal Mesh

The FDA has issued an updated safety communication warning doctors and patients that the placement of surgical mesh through the vagina to treat pelvic organ prolapse may present greater risk for the patient than other options. Many reported complications involving the transvaginal mesh implant include the mesh becoming exposed or protruding out of the vaginal tissue, pain, infection, organ perforation, urinary problems, decreased ability to have sexual intercourse, or even death.